Bristol Myers Squibb discloses death from CAR-T autoimmune therapy trial

Bristol Myers Squibb said Oct. 23 a study participant died from septic pneumonia about six weeks after receiving a dose of a CAR-T cell therapy being tested for multiple sclerosis. The phase 1 trial included 66 patients with highly active relapsing multiple sclerosis or progressive forms of multiple sclerosis. In the study, most adverse events […] The post Bristol Myers Squibb discloses death from CAR-T autoimmune therapy trial appeared first on Becker's Hospital Review | Healthcare...